High Tower Advisors, LLC Nephros Inc Transaction History
High Tower Advisors, LLC
- $71.3 Billion
- Q1 2025
A detailed history of High Tower Advisors, LLC transactions in Nephros Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 55,710 shares of NEPH stock, worth $182,171. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,710
Previous 55,710
-0.0%
Holding current value
$182,171
Previous $82,000
15.85%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NEPH
# of Institutions
18Shares Held
4.24MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.6MShares$11.8 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA204KShares$667,5960.0% of portfolio
-
Bard Associates Inc Chicago, IL143KShares$468,3320.11% of portfolio
-
Geode Capital Management, LLC Boston, MA90.3KShares$295,2450.0% of portfolio
-
Elkhorn Partners Limited Partnership Omaha, NE38.9KShares$127,2810.04% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $33.7M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...